S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
pixel
pixel
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
pixel
pixel
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
pixel
pixel
S&P 500   4,486.46
DOW   35,258.61
QQQ   372.65
pixel
pixel
NASDAQ:ATXI

Avenue Therapeutics SEC Filings & 10K Form

$1.26
-0.01 (-0.79 %)
(As of 10/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.25
$1.29
50-Day Range
$1.26
$1.83
52-Week Range
$1.25
$7.69
Volume71,439 shs
Average Volume232,857 shs
Market Capitalization$21.16 million
P/E RatioN/A
Dividend YieldN/A
Beta0.69

Avenue Therapeutics (NASDAQ:ATXI) SEC Filings

DateFilerForm TypeView
09/21/2021
7:31 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2021
3:03 PM
Avenue Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
7:30 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2021
8:18 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2021
10:17 AM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/14/2021
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2021
8:00 AM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2021
7:02 AM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2021
7:02 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2021
7:04 AM
Avenue Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2021
6:30 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
7:30 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2021
9:37 AM
Avenue Therapeutics (Subject)
VANGUARD INDEX FUNDS (Filed by)
Form SC 13G
12/17/2020
8:02 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2020
3:16 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
4:09 PM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/13/2020
5:10 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2020
3:15 PM
Avenue Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
4:15 PM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/16/2020
4:09 PM
Avenue Therapeutics (Issuer)
KRANZLER JAY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
4:09 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2020
1:26 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2020
8:30 AM
Avenue Therapeutics (Filer)
Form DEFA14A
05/11/2020
8:31 AM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2020
8:00 AM
Avenue Therapeutics (Filer)
Form DEF 14A
04/23/2020
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2020
8:01 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/02/2020
7:10 AM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
3:53 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
3:30 PM
Avenue Therapeutics (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G/A
12/31/2019
5:01 AM
Avenue Therapeutics (Issuer)
InvaGen Pharmaceuticals, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/11/2019
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
3:18 PM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/04/2019
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
3:16 PM
Avenue Therapeutics (Issuer)
Ingram Elizabeth Garrett (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2019
3:17 PM
Avenue Therapeutics (Issuer)
KRANZLER JAY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2019
3:17 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
8:31 AM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2019
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
3:19 PM
Avenue Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
3:17 PM
Avenue Therapeutics (Issuer)
Ingram Elizabeth Garrett (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/01/2019
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:54 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:33 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
3:42 PM
Avenue Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:41 PM
Avenue Therapeutics (Issuer)
Lu Lucy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2019
7:45 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
12:43 PM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2019
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
2:10 PM
Avenue Therapeutics (Filer)
Form DEF 14A
04/30/2019
1:42 PM
Avenue Therapeutics (Issuer)
Moore Thomas Gregory (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2019
1:30 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2019
3:18 PM
Avenue Therapeutics (Subject)
Fortress Biotech, Inc. (Filed by)
Form SC 13D/A
04/15/2019
3:33 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2019
3:17 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2019
3:33 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
4:12 PM
Avenue Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2019
8:16 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2019
3:13 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
10:33 AM
Avenue Therapeutics (Issuer)
Gogtay Jaideep Ashok (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/15/2019
10:28 AM
Avenue Therapeutics (Issuer)
Saxena Nishant (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/11/2019
3:17 PM
Avenue Therapeutics (Subject)
InvaGen Pharmaceuticals, Inc. (Filed by)
Form SC 13D/A
02/11/2019
7:39 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2019
3:31 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2019
11:48 AM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
3:18 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
12:56 PM
Avenue Therapeutics (Filer)
Form DEFA14A
01/22/2019
4:25 PM
Avenue Therapeutics (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G
12/21/2018
11:23 AM
Avenue Therapeutics (Filer)
Form DEFM14A
12/12/2018
12:15 PM
Avenue Therapeutics (Issuer)
Paley Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2018
4:23 PM
Avenue Therapeutics (Filer)
Form PREM14A
11/23/2018
3:00 PM
Avenue Therapeutics (Subject)
InvaGen Pharmaceuticals, Inc. (Filed by)
Form SC 13D
11/14/2018
3:50 PM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/14/2018
3:31 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
11:53 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
8:02 AM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2018
8:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
8:50 PM
Avenue Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:48 PM
Avenue Therapeutics (Issuer)
Lu Lucy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:46 PM
Avenue Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:45 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:43 PM
Avenue Therapeutics (Issuer)
KRANZLER JAY D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:42 PM
Avenue Therapeutics (Issuer)
Reines Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:40 PM
Avenue Therapeutics (Issuer)
WEISS MICHAEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:39 PM
Avenue Therapeutics (Issuer)
Paley Jeffrey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
8:37 PM
Avenue Therapeutics (Issuer)
SAMAD AKHTAR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2018
12:09 PM
Avenue Therapeutics (Issuer)
Vazzano Joseph Walter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2018
12:19 PM
Avenue Therapeutics (Issuer)
Lu Lucy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
3:17 PM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2018
4:31 PM
Avenue Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4/A
06/11/2018
4:37 PM
Avenue Therapeutics (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
7:30 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2018
7:15 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2018
11:15 PM
Avenue Therapeutics (Filer)
Form EFFECT
05/03/2018
8:31 AM
Avenue Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2018
7:00 AM
Avenue Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2018
6:03 AM
Avenue Therapeutics (Filer)
Form DEFA14A
04/30/2018
6:02 AM
Avenue Therapeutics (Filer)
Form DEF 14A
04/25/2018
3:30 PM
Avenue Therapeutics (Issuer)
Herskowitz Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.